SH2D1A anticorps
-
- Antigène Voir toutes SH2D1A Anticorps
- SH2D1A (SH2 Domain Containing 1A (SH2D1A))
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SH2D1A est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Fonction
- Goat polyclonal antibody raised against synthetic peptide of SH2D1A.
- Séquence
- C-QYPVEKKSSA RSTQ
- Réactivité croisée
- Humain
- Attributs du produit
- Antibody Reactive Against Synthetic Peptide.
- Immunogène
- A synthetic peptide corresponding to human SH2D1A.
- Top Product
- Discover our top product SH2D1A Anticorps primaire
-
-
- Indications d'application
-
ELISA (1:32000)
Western Blot (0.2-0.6 μg/mL)
The optimal working dilution should be determined by the end user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4)." dans: Tissue antigens, Vol. 64, Issue 2, pp. 132-44, (2004) (PubMed).
: "
-
Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4)." dans: Tissue antigens, Vol. 64, Issue 2, pp. 132-44, (2004) (PubMed).
-
- Antigène
- SH2D1A (SH2 Domain Containing 1A (SH2D1A))
- Autre désignation
- SH2D1A (SH2D1A Produits)
- Synonymes
- anticorps DSHP, anticorps EBVS, anticorps IMD5, anticorps LYP, anticorps MTCP1, anticorps SAP, anticorps SAP/SH2D1A, anticorps XLP, anticorps XLPD, anticorps RGD1562408, anticorps Gm686, anticorps SH2D1A, anticorps SH2 domain containing 1A, anticorps SH2D1A, anticorps Sh2d1a
- ID gène
- 4068
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-